Navigation Links
BioMS Medical to present at BioContact 2007
Date:9/28/2007

Toronto Stock Exchange Symbol: MS

EDMONTON, Sept. 28 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President Corporate Affairs, will give a corporate presentation at BioContact 2007 in Quebec City.

WHEN: Wednesday 3rd October, 2007 at 2:30pm (EST)

WHERE: Chateau Frontenac, Quebec

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of BioMS Medical with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from ... three key industry events beginning with Patient-Centered Clinical Trials ... in Boston , September 4-5. Patient recruitment ... and Aaron Fleishman will share insights on the ... a variety of tactics – from media to mobile apps ...
(Date:8/28/2014)... new work by a Florida State University research team ... take your temperature, emit white light, and convert photon ... looks like a butterfly. , Biwu Ma, associate professor ... the FAMU-FSU College of Engineering, created the molecule in ... to discover that his creation has many other unique ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a leading ... to support their communication needs with the ... conferencing platform GlobalMeet powered by SoundConnect. The solution ... SoundConnect delivers award winning “results driven” business class ... be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/27/2014)... 2014 Green & Grow Inc. (GGI) ... funding and secured Otter Capital as a significant new ... commercialization of GGI’s Agriplier™ technology, building on recent compelling ... “Since our first meeting, we have been impressed with ... space,” said Alan Sobba, President and CEO of GGI. ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3
... LINCOLN, Neb., Aug. 20 LI-COR announces its second,webinar ... in In Vivo Imaging: Near Infrared Optical Imaging of ... CDT., Near-infrared (NIR) fluorescence offers dramatic benefits for ... depth of penetration and,decreased autofluorescence and light scatter that ...
... 20 MedPredict, a global,provider of pharmaceutical competitive ... providing critical strategic insight for pharma,and biotech companies ... sclerosis,(MS) therapies., Biogen/Elan,s Tysabri has been under ... a rare and potentially fatal brain disease,associated with ...
... Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assignee of the assets ... today that all pharmaceutical,intellectual property will be sold at ... of the pieces of intellectual property for sale is ... of a,branded drug that currently has more than $2 ...
Cached Biology Technology:LI-COR August 27th On-Line Webinar Introduces New Approach to Small Animal In Vivo Imaging 2Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri 2Spherics, Inc. Successful Bidder May Make MHRA Submission 2
(Date:8/28/2014)... Research Careers) Program has announced the travel award recipients ... 18 22, 2014 in San Diego, California. ... students, post doctorates and scientists from underrepresented groups into ... encourage the participation of young scientists at the American ... 16 awards totaling $29,600., The FASEB MARC Program is ...
(Date:8/28/2014)... The support of peer groups and clinicians ... programs, according to recent University of Georgia research. ... the Athens-Clarke County area determined that role models ... of mothers of infants. , "Mothers who received ... at breastfeeding," said study co-author Alex Anderson, an ...
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) ... the American College of Sports Medicine,s Conference on ... in Miami, Florida. These awards are meant ... and scientists from underrepresented groups into the mainstream ... the participation of young scientists at the American ...
Breaking Biology News(10 mins):Breastfeeding study shows need for effective peer counseling programs 2
... Durham, NC The most toxic, brightly colored members of ... says a new study. So-named because some tribes use ... frogs of the Amazon jungle are well known for their ... forest frogs serve to broadcast their built-in chemical weapons: ...
... project to develop and evaluate new tools to control ... a five year, 12 million project involving sixteen partners ... Seventh Framework programme. Because malaria is transmitted by ... disease. Wide scale use of insecticides on bednets ...
... laboratory discoveries into daily clinical practice is important, but ... to the laboratory, to further explore and explain clinically ... basic researchers to understand and address clinical challenges and ... integrate and use new technologies. The key towards ...
Cached Biology News:Fitness tests for frogs? 2€12 million ($16.9 million) project to develop new tools for malaria control 2
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems....
... Alkaline Phosphatase, Calf Intestinal (CIAP), catalyzes ... RNA, and ribo- and deoxyribonucleoside triphosphates. This ... religation of linearized cloning vector DNA by ... may also be used for the dephosphorylation ...
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Biology Products: